Abstract:Inorganic pyrophosphatases (PPases) are enzymes that catalyze the conversion of inorganic pyrophosphate (PPi) into phosphate (Pi). Human inorganic pyrophosphatase 1 (Hu-PPase) exhibits high expression levels in a variety of tumors and plays roles in cell proliferation, apoptosis, invasion and metastasis, making it a promising prognostic biomarker and a target for cancer therapy. Despite its widespread presence, the catalytic mechanism of Hu-PPase in humans remains inadequately understood. The signature motif amino acid sequence (DXDPXD) within the active sites of PPases is preserved across different species. In this research, an enzymatic activity assay revealed that mutations led to a notable reduction in enzymatic function, although the impact of the four amino acids on the activity of the pocket varied. To investigate the influence of these residues on the substrate binding and enzymatic function of PPase, the crystal structure of the Hu-PPase-ED quadruple mutant (D116A/D118A/P119A/D121A) was determined at 1.69 Å resolution. The resulting structure maintained a barrel-like shape similar to that of the wild-type, albeit lacking Mg2+ ions. Molecular docking analysis demonstrated a decreased ability of Hu-PPase-ED to bind to PPi. Further, molecular dynamics simulation analysis indicated that the mutation rendered the loop of Mg2+ ion-binding residues less stable. Therefore, the effect on enzyme activity did not result from a change in the gross protein structure but rather from a mutation that abolished the Mg2+-coordinating groups, thereby eliminating Mg2+ binding and leading to the loss of enzyme activity.

Development of an Engineered Carbamoyl Phosphate Synthetase with Released Sensitivity to Feedback Inhibition by Site-Directed Mutation and Casting Error-Prone PCR.

Directed Evolution of Cephalosporin C Acylase Activity by Error-prone PCR

Carbamate Transport in Carbamoyl Phosphate Synthetase: a Theoretical and Experimental Investigation.

Modulation of Human UMP/CMP Kinase Affects Activation and Cellular Sensitivity of Deoxycytidine Analogs.

Unraveling the therapeutic potential of carbamoyl phosphate synthetase 1 (CPS1) in human diseases

Enhancing 2‐Pyrone Synthase Efficiency by High‐Throughput Mass‐Spectrometric Quantification and In Vitro/In Vivo Catalytic Performance Correlation

Modularized Reconstruction of Pyrimidine Pathway in Escherichia Coli for Enhanced Pyrimidine Nucleosides Biosynthesis

Engineering Substrate Promiscuity of Nucleoside Phosphorylase Via an Insertions-Deletions Strategy

Specific Mutations Reverse Regulatory Effects of Adenosine Phosphates and Increase Their Binding Stoichiometry in CBS Domain-Containing Pyrophosphatase

Reshaping the binding pocket of purine nucleoside phosphorylase for improved production of 2-halogenated-2′-deoxyadenosines

Tuning enzymatic properties by protein engineering toward catalytic tetrad of carbonyl reductase

Rational engineering of homospermidine synthase for enhanced catalytic efficiency toward spermidine synthesis

Nonvanishing univalent functions

Structural and biochemical characterization of active sites mutant in human inorganic pyrophosphatase

Improved efficiency of a novel methyl parathion hydrolase using consensus approach

Mechanism of Nucleotide-Dependent Allosteric Regulation in Aspartate Transcarbamoylase

Crystal structure of urethanase from Candida parapsilosis and insights into the substrate-binding through in silico mutagenesis and improves the catalytic activity and stability

Perspectives: Preventive cardiology in the new millennium: a virtual specialty?

Cytoophidia: a conserved yet promising mode of enzyme regulation in nucleotide metabolism

Production of uridine 5′-monophosphate by Corynebacterium ammoniagenes ATCC 6872 using a statistically improved biocatalytic process

Engineering allosteric inhibition of homoserine dehydrogenase by semi-rational saturation mutagenesis screening